Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis and comorbid asthma status

B. Emmanuel (Gaithersburg, United States of America), M. Biswas (Gaithersburg, United States of America), M. Scott (Bollington, United Kingdom), M. Small (Bollington, United Kingdom), L. Lee (Bollington, United Kingdom), S. Chen (Gaithersburg, United States of America), S. Ruiz (Barcelona, Spain)

Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Emmanuel (Gaithersburg, United States of America), M. Biswas (Gaithersburg, United States of America), M. Scott (Bollington, United Kingdom), M. Small (Bollington, United Kingdom), L. Lee (Bollington, United Kingdom), S. Chen (Gaithersburg, United States of America), S. Ruiz (Barcelona, Spain). Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis and comorbid asthma status. 1590

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improvement in rhinosinusitis health related quality of life in patients with severe eosinophilic asthma
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017


Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016



Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2002; 19: 202
Year: 2002


Is quality of life impairment in asthma comparable to chronic urticaria?
Source: Eur Respir J 2007; 30: Suppl. 51, 627s
Year: 2007

Area-level socio-economic status and health status among adults with asthma and rhinitis
Source: Eur Respir J 2006; 27: 85-94
Year: 2006



Monitoring asthma in childhood: symptoms, exacerbations and quality of life
Source: Eur Respir Rev 2015; 24: 187-193
Year: 2015



Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Patients with asthma and comorbid allergic rhinitis: Is optimal quality of life achievable in real life?
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011


Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


The association between common mental disorders and quality of life in adolescents with asthma
Source: Annual Congress 2008 - Early life risk factors for childhood asthma: evidence from birth cohort studies II
Year: 2008

Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Respiratory symptoms are associated with impaired health-related quality of life in subjects with neither asthma nor COPD
Source: Annual Congress 2009 - Risk factors for asthma and pneumonia
Year: 2009


Dysfunctional breathing in patients with severe asthma is associated with poor asthma control and low quality of life.
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


The relationship between asthma symptom control scores and rhinosinusitis scores in difficult-to-treat asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008


High steroid burden in children with asthma and nasal symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 288s
Year: 2001

Comorbidity of asthma and other allergic diseases and impairment of quality of life
Source: Eur Respir J 2005; 26: Suppl. 49, 164s
Year: 2005

Prognosis symptoms, quality of life and comorbidity relationship with cough in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Impact of chronic rhinosinusitis on clinical presentation in patients with asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 238s
Year: 2006